Global Atrial Fibrillation Market: Restraint
The major factors that hinder growth of the global atrial fibrillation market include product recalls. For instance, in February 2019, Medtronic Plc received U.S. Food and Drug Administration (FDA) product recall for implanted cardiac pacemakers, which affected 13,440 devices manufactured and distributed between March 2017 and January 2019.
Restraints & Challenges:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients